Surgical outcomes of infective endocarditis in pediatrics : Moving the needle to a contemporary, multidisciplinary approach
Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Infective endocarditis (IE) is an uncommon disease in children that, when present, is accompanied by significant morbidity and mortality. The presence of congenital heart disease often complicates management. The aim of the present study is to describe the characteristics and outcomes of children undergoing surgery for IE.
METHODS: A retrospective chart review from 2004 to 2020 was conducted to identify consecutive patients younger than age 20 years with IE undergoing surgery.
RESULTS: A total of 94 patients with IE were identified, of whom 47 underwent surgery at a median age of 16.7 years. Thirty-one patients (65.95%) had congenital heart disease. Vegetation and embolic phenomena occurred in 41 and 29 patients (87.23% and 61.7%), respectively, with the brain as most common location (57.1%). Native valve involvement had a greater tendency to embolize (P < .001). Staphylococcus spp was the most common organism (49%). The mitral valve was the most affected (31.9%). Seven (14.9%) patients had multivalvar involvement and valve replacement was the most common procedure performed (37 patients; 78.7%). There were 3 operative deaths (6.4%). Median length of hospital stay was 21 days. Risk factors for prolonged hospital stay were time to surgery in days (P < .001) and native valvar involvement (P = .05). Five patients (10.6%) had postoperative recurrent IE. Survival at 1 and 5 years was 93.6% and 89.4%, respectively.
CONCLUSIONS: Children with IE can undergo surgery with acceptable results. The morbidity, but not mortality, is driven by embolic complications. Staphylococcus spp and native valve involvement are significant risk factors. VIDEO ABSTRACT.
| Errataetall: |
CommentIn: J Thorac Cardiovasc Surg. 2023 Jan;165(1):285-286. - PMID 35610071 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:165 |
|---|---|
| Enthalten in: |
The Journal of thoracic and cardiovascular surgery - 165(2023), 1 vom: 07. Jan., Seite 275-284 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Carrillo, Sergio A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Embolization |
|---|
| Anmerkungen: |
Date Completed 16.12.2022 Date Revised 21.12.2022 published: Print-Electronic CommentIn: J Thorac Cardiovasc Surg. 2023 Jan;165(1):285-286. - PMID 35610071 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jtcvs.2022.03.031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340660929 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340660929 | ||
| 003 | DE-627 | ||
| 005 | 20231226005916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jtcvs.2022.03.031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1135.xml |
| 035 | |a (DE-627)NLM340660929 | ||
| 035 | |a (NLM)35537892 | ||
| 035 | |a (PII)S0022-5223(22)00389-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Carrillo, Sergio A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Surgical outcomes of infective endocarditis in pediatrics |b Moving the needle to a contemporary, multidisciplinary approach |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2022 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Thorac Cardiovasc Surg. 2023 Jan;165(1):285-286. - PMID 35610071 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Infective endocarditis (IE) is an uncommon disease in children that, when present, is accompanied by significant morbidity and mortality. The presence of congenital heart disease often complicates management. The aim of the present study is to describe the characteristics and outcomes of children undergoing surgery for IE | ||
| 520 | |a METHODS: A retrospective chart review from 2004 to 2020 was conducted to identify consecutive patients younger than age 20 years with IE undergoing surgery | ||
| 520 | |a RESULTS: A total of 94 patients with IE were identified, of whom 47 underwent surgery at a median age of 16.7 years. Thirty-one patients (65.95%) had congenital heart disease. Vegetation and embolic phenomena occurred in 41 and 29 patients (87.23% and 61.7%), respectively, with the brain as most common location (57.1%). Native valve involvement had a greater tendency to embolize (P < .001). Staphylococcus spp was the most common organism (49%). The mitral valve was the most affected (31.9%). Seven (14.9%) patients had multivalvar involvement and valve replacement was the most common procedure performed (37 patients; 78.7%). There were 3 operative deaths (6.4%). Median length of hospital stay was 21 days. Risk factors for prolonged hospital stay were time to surgery in days (P < .001) and native valvar involvement (P = .05). Five patients (10.6%) had postoperative recurrent IE. Survival at 1 and 5 years was 93.6% and 89.4%, respectively | ||
| 520 | |a CONCLUSIONS: Children with IE can undergo surgery with acceptable results. The morbidity, but not mortality, is driven by embolic complications. Staphylococcus spp and native valve involvement are significant risk factors. VIDEO ABSTRACT | ||
| 650 | 4 | |a Video-Audio Media | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a embolization | |
| 650 | 4 | |a endocarditis team | |
| 650 | 4 | |a infective endocarditis | |
| 650 | 4 | |a pediatric | |
| 650 | 4 | |a surgery | |
| 700 | 1 | |a Duenas, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Blaney, Cristin |e verfasserin |4 aut | |
| 700 | 1 | |a Eisner, Mariah |e verfasserin |4 aut | |
| 700 | 1 | |a Nandi, Deipanjan |e verfasserin |4 aut | |
| 700 | 1 | |a McConnell, Patrick I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of thoracic and cardiovascular surgery |d 1959 |g 165(2023), 1 vom: 07. Jan., Seite 275-284 |w (DE-627)NLM000033510 |x 1097-685X |7 nnns |
| 773 | 1 | 8 | |g volume:165 |g year:2023 |g number:1 |g day:07 |g month:01 |g pages:275-284 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtcvs.2022.03.031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 165 |j 2023 |e 1 |b 07 |c 01 |h 275-284 | ||